Crinetics Pharmaceuticals Announces $15.0 Million Private Placement with Frazier Healthcare Partners
SAN DIEGO, July 29, 2021 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related…
